animals treated with control or smg-2 RNAi (n=2). (e) RT-PCR for PTC-containing rpl-12 (rpl-

12(PTC)) was normalized with rpl-12 (rpl-12(WT)) transcripts, which do not contain PTC (n=3).
Error bars represent SEM (two-tailed Student's t-test, ***p < 0.001). interquartile range (IQR), which is the distance between the lower and upper quartiles of the data (**p < 0.01, ***p < 0.001, Wilcox rank sum test). (e) The eft-3 pre-mRNA levels after DRB treatment (500 μg/ml) at different time points (2, 4, 6 hours) were examined by using qRT-PCR (n=3).
Supplementary
Following are our descriptions regarding how we optimized experimental conditions for our RNA half-life assays. We treated worms with DRB, one of established transcription inhibitors used for measuring mRNA half-life 5, 6 , to block transcription. As DRB is dissolved in DMSO, which can be toxic to worms 7 , we first tested the effects of various concentrations of DMSO (1-5%) on the growth of worms. We found that 1% DMSO was the highest concentration that did not delay the development of C. elegans ( Supplementary Fig. 10a ). Next we tried to titrate optimal concentrations of DRB that inhibited growth, which reflects inhibited transcription 8 , in wild-type, daf-2, smg-2, and smg-2; daf-2 mutants. We found that over 200 μg/ml of DRB treatment was sufficient for inhibiting the growth (Supplementary Fig. 10b ). Next, we measured the pre-mRNA levels of eft-3, (a positive control) by using qRT-PCR to determine whether treatments with DRB inhibited transcription as previously described 8 . We found that 200 μg/ml of DRB partially decreased transcription in wild-type, but did not in daf-2 mutants (Supplementary Fig. 10c) . A much higher concentration of DRB (1000 μg/ml of DRB) inhibited transcription in daf-2 mutants, whereas the same concentration of DRB killed wild-type worms.
Thus, we concluded that L1 larval worms were not suitable for our mRNA half-life assays that require comparing daf-2 mutants and wild-type animals. We therefore changed our strategy to examine the RNA half-lives of adult worms. We found that 500 μg/ml of DRB treatment successfully inhibited transcription in wild-type, daf-2(-), and smg-2(-); daf-2(-) mutant animals, although it seems that daf-2 mutants are more resistant to DRB than wild-type at early time points (2 hr and 4 hr) ( Supplementary Fig. 10d ,e). 
Supplementary Figure 11
were examined by qRT-PCR (n ≥ 4). Error bars represent SEM (two-tailed Student's t-test, *p < 0.05, ***p < 0.001).
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